+41.1%
CVS vs DXCM
+6.5%
+34.5%
-16.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DXCM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -3.8% | +3.1% | -0.7% |
| 7D | -1.6% | -6.2% | +4.7% | -1.6% |
| 30D | +0.4% | -0.3% | +0.6% | +0.4% |
| 3M | -0.4% | +10.3% | -10.8% | -0.2% |
| 6M | +25.1% | +24.1% | +1.0% | +26.1% |
| YTD | +23.9% | +27.4% | -3.5% | +24.9% |
| 1Y | +41.1% | +8.4% | +32.7% | +38.2% |
| All | +41.1% | +6.5% | +34.5% | +38.2% |
Cumulative growth
Daily Returns
Daily percentage return beside DXCM.
Daily Out/Under-Performance
Portfolio return minus DXCM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DXCM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DXCM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling